Preadmission metformin use and mortality among intensive care patients with diabetes: A cohort study

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Christiansen, Christian F ^a   Johansen, Martin B ^a   Christensen, Steffen ^a   O'Brien, James M ^b   Tønnesen, Else ^a   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; DENMARK; DISEASE ASSOCIATION; DISEASE DURATION; DRUG FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT; DIABETES MELLITUS, TYPE 2; HEALTH SURVEY; MORTALITY; PROCEDURES; TRENDS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INTENSIVE CARE UNITS; MALE; METFORMIN; MIDDLE AGED; MORTALITY; PATIENT ADMISSION; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 84883511890     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12886     Document Type: Article

References (49)

1. American Diabetes Association Standards of medical care in diabetes-2013. Diabetes Care 2013, 36:S11-S66. American Diabetes Association.
2. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203. 10.2337/dc08-9025, 2606813, 18945920.
3. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med 2002, 137:25-33. 10.7326/0003-4819-137-1-200207020-00009, 12093242.
4. Prospective UK, . Diabetes Study (UKPDS) group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:854-865. Diabetes Study (UKPDS) group.
5. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589. 10.1056/NEJMoa0806470, 18784090.
6. Selvin E, Bolen S, Yeh HC, Wiley C, Wilson LM, Marinopoulos SS, Feldman L, Vassy J, Wilson R, Bass EB, Brancati FL. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008, 168:2070-2080. 10.1001/archinte.168.19.2070, 2765722, 18955635.
7. Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011, 60:1-23. 10.1016/j.metabol.2010.09.010, 3746516, 21134520.
8. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs 2003, 63:1879-1894. 10.2165/00003495-200363180-00001, 12930161.
9. Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol 2011, 162:1498-1508. 10.1111/j.1476-5381.2010.01126.x, 3057288, 21091653.
10. Grant PJ. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 2003, 29:6S44-6S52.
11. Zmijewski JW, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G, Siegal GP, Abraham E. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med 2008, 178:168-179. 10.1164/rccm.200710-1602OC, 2453511, 18436790.
12. Ansari G, Mojtahedzadeh M, Kajbaf F, Najafi A, Khajavi MR, Khalili H, Rouini MR, Ahmadi H, Abdollahi M. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Adv Ther 2008, 25:681-702. 10.1007/s12325-008-0075-1, 18636232.
13. Duncan AI, Koch CG, Xu M, Manlapaz M, Batdorf B, Pitas G, Starr N. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg 2007, 104:42-50. 10.1213/01.ane.0000242532.42656.e7, 17179241.
14. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Ryden L. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J 2008, 29:166-176.
15. Horsdal HT, Johnsen SP, Sondergaard F, Rungby J. Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study. Diabetologia 2008, 51:567-574. 10.1007/s00125-008-0947-6, 18283428.
16. Lamanna C, Monami M, Marchionni N, Mannucci E. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes Metab 2011, 13:221-228. 10.1111/j.1463-1326.2010.01349.x, 21205121.
17. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
18. Toft P, Tonnesen E. Immune-modulating interventions in critically ill septic patients: pharmacological options. Expert Rev Clin Pharmacol 2011, 4:491-501. 10.1586/ecp.11.25, 22114858.
19. Christiansen CF, Johansen MB, Christensen S, O'Brien JM, Tonnesen E, Sorensen HT. Type 2 diabetes and 1-year mortality in intensive care unit patients. Eur J Clin Invest 2012, 43:238-247.
20. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
21. The Ministry of Health Health care in Denmark 2008, http://www.sum.dk/Aktuelt/Publikationer/~/media/Filer%20-%20Publikationer_i_pdf/2008/UK_Healthcare_in_dk/pdf.ashx, The Ministry of Health.
22. Frank L. Epidemiology, When an entire country is a cohort. Science 2000, 287:2398-2399. 10.1126/science.287.5462.2398, 10766613.
23. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-268.
24. Christiansen CF, Christensen S, Johansen MB, Larsen KM, Tonnesen E, Sorensen HT. The impact of pre-admission morbidity level on 3-year mortality after intensive care: a Danish cohort study. Acta Anaesthesiol Scand 2011, 55:962-970.
25. Blichert-Hansen L, Nielsson MS, Nielsen RB, Christiansen CF, Norgaard M. Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish National Patient Registry: a short report. Clin Epidemiol 2013, 5:9-12. 3555432, 23359787.
26. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007, 30:2251-2257. 10.2337/dc06-2417, 17595354.
27. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010, 2:273-279. 2998817, 21152254.
28. Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW. Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 2011, 3:133-138. 3072155, 21487452.
29. Horsdal HT, Sondergaard F, Johnsen SP, Rungby J. Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study. Pharmacoepidemiol Drug Saf 2011, 20:331-337. 10.1002/pds.2097, 21442682.
30. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003, 158:915-920. 10.1093/aje/kwg231, 14585769.
31. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758. 10.1001/jama.286.14.1754, 11594901.
32. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011, 11:83. 10.1186/1471-2288-11-83, 3125388, 21619668.
33. Christensen S, Thomsen RW, Johansen MB, Pedersen L, Jensen R, Larsen KM, Larsson A, Tonnesen E, Sorensen HT. Preadmission statin use and one-year mortality among patients in intensive care - a cohort study. Crit Care 2010, 14:R29. 10.1186/cc8902, 2887131, 20214779.
34. Christensen S, Johansen MB, Tonnesen E, Larsson A, Pedersen L, Lemeshow S, Sorensen HT. Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study. Crit Care 2011, 15:R87. 10.1186/cc10085, 3219345, 21385356.
35. Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, Losche W. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med 2010, 38:32-37. 10.1097/CCM.0b013e3181b4275c, 19770746.
36. Gammelager H, Christiansen CF, Johansen MB, Tonnesen E, Jespersen B, Sorensen HT. One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study. Crit Care 2012, 16:R124. 10.1186/cc11420, 3580703, 22789072.
37. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
38. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009, 20:488-495. 10.1097/EDE.0b013e3181a819a1, 2744485, 19525685.
39. Glynn RJ, Schneeweiss S, Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 2006, 98:253-259. 10.1111/j.1742-7843.2006.pto_293.x, 1790968, 16611199.
40. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006, 59:437-447. 1448214, 16632131.
41. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001, 54:387-398. 10.1016/S0895-4356(00)00321-8, 11297888.
42. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007, 134:1128-1135. 10.1016/j.jtcvs.2007.07.021, 17976439.
43. Horsdal HT, Ulrichsen SP, Thomsen RW, Norgaard M, Larsen FB, Sorensen HT. Lifestyle Profile among Users of Antidiabetic Treatments [abstract]. Pharmacoepidemiol Drug Saf 2011, 20:S292.
44. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002, 162:434-437. 10.1001/archinte.162.4.434, 11863476.
45. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2011, 34:1431-1437. 10.2337/dc10-2361, 3114336, 21617112.
46. Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring) 2008, 16:515-521. 10.1038/oby.2007.102, 18239602.
47. O'Brien JM, Philips GS, Ali NA, Aberegg SK, Marsh CB, Lemeshow S. The association between body mass index, processes of care, and outcomes from mechanical ventilation: a prospective cohort study. Crit Care Med 2012, 40:1456-1463. 10.1097/CCM.0b013e31823e9a80, 22430246.
48. Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009, 37:2191-2196. 10.1097/CCM.0b013e3181a02490, 19487945.
49. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010, CD002967.